Trial intelligence / Profile preview

Humira in active psoriatic arthritis (STEREO)

NCT00235885Phase 3Completed

Sponsor
Abbott Laboratories
Start
Jul 2005
Modality
Monoclonal Antibodies
Countries
1
01

Overview

A Phase 3 trial of Trudexa in psoriatic arthritis (PsA), sponsored by Abbott Laboratories. Started Jul 2005; status: completed.

02

Drugs

Trudexa
03

Conditions

psoriatic arthritis (PsA)

Beyond the preview

Go deeper on NCT00235885.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00235885.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call